Ian White

Founder

Presentations

From Jellyfish to Humans: The Science of Turning Back Time

What if aging isn't the inevitable decline we've been told it is? Dr. Ian White, regenerative medicine pioneer and founder of Neobiosis, challenges conventional thinking about biological aging by exploring nature's most radical examples—from immortal jellyfish that reverse their age to lobsters that never age at all. Drawing on two decades of stem cell research at Harvard, Cornell, and beyond, he presents compelling evidence that aging can be accelerated, slowed, paused, and even reversed. This provocative session examines the mechanisms behind age reversal, from Yamanaka factors to perinatal tissues, and explores whether regenerative medicine holds the key to treating aging itself as a disease.

What Birth Tissues Reveal About Your Body's Built-In Repair System

Your body already contains the machinery for regeneration. Researchers are now exploring how perinatal birth tissues, rich in growth factors, extracellular vesicles, and matrix, may hold clues to restoring the repair capacity that declines with age.

About

Dr. Ian White is a leading expert in regenerative medicine and stem cell biology with over 20 years of experience spanning both academia and industry. His academic career includes field-defining work at prestigious institutions including Dartmouth College, Harvard University, and Cornell University.

At Dartmouth, he studied the genetics of gamete biology before being recruited to Harvard, where he worked under the mentorship of world-renowned immunologist Dr. Laurie Glimcher on hematopoietic stem cells and immune cell biology, co-authoring several high-impact peer-reviewed manuscripts. He earned his Ph.D.

from the Ansary Stem Cell Institute at Cornell University, where he developed an innovative in vitro method for culture-expanding autologous hematopoietic stem cells in an artificial vascular niche—technology that has been commercialized to treat cancer patients undergoing bone marrow ablation. Following his doctoral work, he conducted groundbreaking research in embryonic stem cell biology under Dr. Stephen Dalton, whose pioneering contributions influenced Nobel laureate Dr.

Shinya Yamanaka's development of induced pluripotent stem cells. Dr. White subsequently relocated to the University of Miami's Miller School of Medicine, where he published research on peripheral nerve signaling in cardiac regeneration.

In 2018, he joined IMAC Regeneration Centers as Chief Scientific Officer to facilitate their NASDAQ public listing. Today, Dr. White serves as Founder, CEO, and Chief Scientific Officer of Neobiosis, a perinatal regenerative tissue research and manufacturing CDMO facility focused on developing innovative therapies using perinatal birth tissues, cells, extracellular vesicles, and matrices.

He is Vice President and member of the Board of Directors of the American College of Regenerative Medicine, co-founder of the Space-Aging Research Institute competing in the HealthSpan XPRIZE, member of the Scientific Board of Advisors for the Alliance for Longevity Initiatives, and serves in leadership roles at multiple regenerative medicine organizations.

Sources

[1]Neobiosis Official Website [2]Liverpool School of Tropical Medicine - Dr. Ian White Profile [3]American Academy of Anti-Aging Medicine - Ian White Profile [4]AMMG Conference Faculty - Ian White [5]DrTalks Expert Profile - Ian White [6]Top Doctor Magazine - The Emerging Field of Regenerative Medicine [7]BioHackYourself - Dr. Ian White: A Pioneer in Regenerative Medicine

Career Highlights

Founder, CEO, and Chief Scientific Officer of Neobiosis, a perinatal regenerative tissue research and manufacturing CDMO facility
Developed commercialized in vitro method for culture-expanding autologous hematopoietic stem cells at Cornell University, now used to treat cancer patients
Vice President and Board Member of the American College of Regenerative Medicine; co-founder of Space-Aging Research Institute competing in HealthSpan XPRIZE
Published groundbreaking research on cardiac regeneration and stem cell biology at leading institutions including Harvard, Cornell, and University of Miami